Chris Twelves is Professor of Clinical Cancer Pharmacology and Oncology in the Leeds Institute of Cancer and Pathology (LICAP) at the University of Leeds and Honorary Consultant in Oncology at Leeds Teaching Hospitals.
His first degree was in Pharmacology and Experimental Medicine before qualifying in Medicine and training as a medical oncologist with a particular interest in new drug development and clinical pharmacology; his clinical practice has been in colorectal and breast cancer. Professor Twelves’ has been directly involved in the development of several important cancer drugs.
Professor Twelves also heads the Experimental Cancer Medicine Centre in Leeds and is Head of Section of Oncology and Clinical Research at the Leeds Cancer Research UK Centre.
Professor Twelves has published over 200 papers in journals including the New England Journal of Medicine, Lancet and Journal of Clinical Oncology and spoken at numerous international meetings. He has also edited, or contributed to, several books including one on Phase I clinical trials and another on the design of Phase II clinical trials.